SPY—
QQQ—
DIA—
NVDA—
AAPL—
TSLA—
MSFT—
BTC-USD—
15-min delayed
Home Market News Price Targets Penny Stocks Crypto Economy Commodities Education
Stocks About Contact

Nexentis Technologies Inc. Common Stock

NXTS XNAS
$1.58 -0.15 (-8.82%) ▼ 15-min delayed
Open
$1.67
High
$1.74
Low
$1.55
Volume
7.8K
Market Cap
$750.7K

About Nexentis Technologies Inc. Common Stock

Nexentis Technologies Inc, is engaged in redefining mitochondrial drug discovery with help of its wholly owned biotechnology subsidiary, MitoCareX Bio focused on drug discovery company dedicated to developing first-in-class therapeutics for inflammatory metabolic diseases and cancer by targeting specific metabolic pathways. The company is also focused on sustainable operations in various industries such as solar projects, and oncology biotechnology.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 9 Website →

Related Market News

No specific coverage for NXTS yet. Check out our latest market news or earnings calendar.

Get NXTS Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Nexentis Technologies Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.